Who invested in Peptyde Bio?
Peptyde Bio's investors include Wells Fargo.
United States · Pre-seed startup
Funding summaryUpdated 26 Oct 2026
$1.2Mraised across 1 round since 2022, from 1 source
Peptyde Bio's investors include Wells Fargo.
Peptyde Bio has raised $1.2M across 1 round since 2022.
Peptyde Bio's most recent round was a Pre-seed of $1.2M in Nov 2022.
Its most recent round, $1.2M in Nov 2022, is also its largest on record.
Peptyde Bio's first round on record, in Nov 2022, was backed by Wells Fargo.
Peptyde Bio's latest named round is a Pre-seed, in Nov 2022.
Peptyde Bio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.